Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07086560 · ClinicalTrials.gov registry record
PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
A clinical trial of Supraventricular Tachycardia (SVT), sponsored by University of Iowa.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT07086560 is a study of Supraventricular Tachycardia (SVT) that is actively recruiting participants, run by University of Iowa. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07086560, a study of Supraventricular Tachycardia (SVT), is actively recruiting participants, sponsored by University of Iowa.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Supraventricular tachycardia (SVT) is a dysrhythmia characterized rapid heart rate, typically with rapid onset. SVT accounts for over 50,000 emergency department visits per year. Of patients with regular, narrow-complex SVT, the mainstay of therapy includes adenosine and diltiazem. Adenosine is recommend by American and European guidelines as first-line therapy, however adenosine carries unique side effects that are potentially distressing to patients, including: "feeling of impending death or doom", flushing, anxiety, shortness of breath, and chest discomfort. Diltiazem does not carry this side effect profile, but has typically been reserved as second-line treatment due to side effects of low blood pressure associated with this class of medications. Diltiazem and adenosine have not been well studied head-to-head to compare safety and efficacy of their treatment for SVT. The purpose of this study is to evaluate safety and efficacy of adenosine and diltiazem for SVT in the ED (as completed through chart review of specific patient-level outcomes) and capture patient and clinician perspectives of medication satisfaction (through administration of questionnaires).
Conditions Studied
Interventions
- DRUG IV adenosine
- DRUG IV diltiazem
Study Locations (1)
Iowa
- University of Iowa Health Care - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07086560
The ClinicalTrials.gov registry entry for NCT07086560 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Supraventricular Tachycardia (SVT) appearing as the primary indexed condition, and to 2 interventions - of which IV adenosine is the first listed.
NCT07086560 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT07086560 about?
NCT07086560 is a clinical study titled "PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department". Supraventricular tachycardia (SVT) is a dysrhythmia characterized rapid heart rate, typically with rapid onset. SVT accounts for over 50,000 emergency department visits per year. Of patients with regular, narrow-complex SVT, the mainstay of therapy includes adenosine and diltiazem. Adenosine is reco...
What is the current status of trial NCT07086560?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-04-04. Estimated completion is 2026-12.
What conditions does trial NCT07086560 study?
This clinical trial studies the following conditions: Supraventricular Tachycardia (SVT).
What interventions are being tested in trial NCT07086560?
The interventions under investigation include: IV adenosine (DRUG), IV diltiazem (DRUG).
Who is sponsoring clinical trial NCT07086560?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07086560 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Supraventricular Tachycardia (SVT)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.